Synopsis: Healthcare stock gained 13 percent after the company reported strong Q1 FY27 results, with profit rising 279 percent YoY and margins improving on healthy revenue growth.
The share of this company, which is a digital-first consumer healthcare company specializing in home healthcare, wellness, and chronic disease monitoring products, gained traction after robust Q1 numbers
With a market capitalization of Rs 302 crore, Nureca Ltd’s share on Wednesday made a day high of Rs 330.10 per share, up by 13 percent from its previous close price of Rs 292.05 per share. The share of this company has given 24 percent over the last year.
QoQ View
The revenue from operations grew by 14 percent QoQ to Rs 40.3 crore in Q1 FY27 from Rs 35.4 crore in Q4 FY26, and EBITDA improved to Rs 5.2 crore in Q1 FY27, turning around from a loss of Rs 4.7 crore in Q4 FY26, with the EBITDA margin expanding to 12 percent from negative 13 percent.
This was accompanied by a PAT growth to Rs 3.1 crore in Q1 FY27, turning around from a net loss of Rs 6.0 crore in Q4 FY26, resulting in a PAT margin expansion to 7.4 percent from negative 16.5 percent.
YoY View
The revenue from operations grew by 18 percent YoY to Rs 40.3 crore in Q1 FY27 from Rs 34.2 crore in Q1 FY26, and EBITDA grew by 160 percent to Rs 5.2 crore in Q1 FY27 from Rs 2.0 crore in Q1 FY26, with the EBITDA margin expanding to 12 percent from 5 percent.
This was accompanied by a Profit After Tax growth of 279percent to Rs 3.07 crore in Q1 FY27 from Rs 0.81 crore in Q1 FY26, resulting in a PAT margin expansion to 7.4 percent from 2.4 percent.
Strong Financial Position
The company remained debt-free in Q1 FY27 and continued to maintain a strong balance sheet. It also had Rs 110 crore in net cash and investments, giving it enough financial strength to support future growth.
Better Margins and Business Growth
The company’s operating performance improved during the quarter, with EBITDA margin rising to 12 percent in Q1 FY27, compared to 5 percent in Q1 FY26 and negative 13 percent in Q4 FY26. The improvement was mainly driven by better cost control and higher gross margins.
Offline and Digital Business Expansion
The offline business continued to grow, with revenue increasing 57 percent YoY and 14 percent QoQ. Offline sales made up 12.4 percent of total revenue, supported by a larger distributor and super-stockist network. At the same time, in-house manufacturing contributed 27 percent of total revenue, while the Dr Trust 360 platform expanded to 2.4 million users with new AI-powered health features.
About the Company
Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products. It sells products under brands such as Dr Trust, Dr Physio, and Trumom. It offers products across chronic care, lifestyle, nutrition, mother and baby care, and connected devices. The company also operates the Dr Trust 360 digital health platform and has a presence in international markets through its US subsidiary.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
